4.6 Article

Controlled release of metronidazole from composite poly-ε-caprolactone/alginate (PCL/alginate) rings for dental implants

期刊

DENTAL MATERIALS
卷 29, 期 6, 页码 656-665

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.dental.2013.03.014

关键词

Localized drug delivery; Dental implants; Poly-epsilon-caprolactone; Alginate; Solvent casting; Metronidazole

资金

  1. US NSF [0846610]
  2. Bioengineering Center-University Strategic Organization (USO) initiative
  3. Directorate For Engineering
  4. Div Of Civil, Mechanical, & Manufact Inn [0846610] Funding Source: National Science Foundation
  5. Div Of Civil, Mechanical, & Manufact Inn
  6. Directorate For Engineering [1359587] Funding Source: National Science Foundation

向作者/读者索取更多资源

Objective. Dental implants provide support for dental crowns and bridges by serving as abutments for the replacement of missing teeth. To prevent bacterial accumulation and growth at the site of implantation, solutions such as systemic antibiotics and localized delivery of bactericidal agents are often employed. The objective of this study was to demonstrate a novel method of controlled localized delivery of antibacterial agents to an implant site using a biodegradable custom fabricated ring. Methods. The study involved incorporating a model antibacterial agent (metronidazole) into custom designed poly-epsilon-caprolactone/alginate (PCL/alginate) composite rings to produce the intended controlled release profile. The rings can be designed to fit around the body of any root form dental implants of various diameters, shapes and sizes. Results. In vitro release studies indicate that pure (100%) alginate rings exhibited an expected burst release of metronidazole in the first few hours, whereas Alginate/PCL composite rings produced a medium burst release followed by a sustained release for a period greater than 4 weeks. By varying the PCL/alginate weight ratios, we have shown that we can control the amount of antibacterial agents released to provide the minimal inhibitory concentration (MIC) needed for adequate protection. The fabricated composite rings have achieved a 50% antibacterial agent release profile over the first 48 h and the remaining amount slowly released over the remainder of the study period. The PCL/alginate agent release characteristic fits the Ritger-Peppas model indicating a diffusion-based mechanism during the 30-day study period. Significance. The developed system demonstrates a controllable drug release profile and the potential for the ring to inhibit bacterial biofilm growth for the prevention of diseases such as peri-implantitis resulting from bacterial infection at the implant site. (C) 2013 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据